See how our panel of regulatory experts rated the agency on everything from transparency and consistency to UDI implementation.
The relationship between FDA and the medtech industry seems to have been improving in recent years, but in which areas is the agency getting better? We asked a panel of regulatory experts to grade FDA's performance in everything from transparency and consistency to implementation of the unique device identification system. The panel members were:
Here's how the regulator stacked up.
[image courtesy of JAKER 5000/iSTOCKPHOTO.COM]